Sector
PharmaceuticalsOpen
₹56.1Prev. Close
₹56.03Turnover(Lac.)
₹3,317.57Day's High
₹56.69Day's Low
₹54.952 Week's High
₹69.8952 Week's Low
₹34Book Value
₹42.92Face Value
₹1Mkt Cap (₹ Cr.)
2,106.23P/E
44.14EPS
1.25Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 90.88 | 30.74 | 30.74 | 7.68 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 319.39 | 234.83 | 196.44 | 87.21 |
Net Worth | 410.27 | 265.57 | 227.18 | 94.89 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Revenue | 249.4 | 187.94 |
yoy growth (%) | 32.7 | |
Raw materials | -122.6 | -99.01 |
As % of sales | 49.15 | 52.68 |
Employee costs | -20.02 | -16.83 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Profit before tax | 48.96 | 37.11 |
Depreciation | -2.9 | -2.31 |
Tax paid | -10.93 | -8.05 |
Working capital | 86.83 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 32.7 | |
Op profit growth | 34.98 | |
EBIT growth | 30.93 | |
Net profit growth | 30.86 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 488.24 | 398.96 | 302.05 | 250.29 | 192.76 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 488.24 | 398.96 | 302.05 | 250.29 | 192.76 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 20.52 | 11.69 | 6.67 | 2.63 | 3.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
Rabindra Prasad Sinha
Executive Vice Chairman
Chidambarnathan Shanmuganathan
Managing Director & CEO
Amit Raj Sinha
Independent Director
Dhanalakshmi Guntaka
Independent Director
Bindu Vinodhan
Company Sec. & Compli. Officer
VIVEK KUMAR
229/1 & 90 4th Floor Kalyans,
Tulsiram Chambers Madinaguda,
Telangana - 500049
Tel: 91-040-40114874/75/76
Website: http://www.sigachi.com
Email: [email protected]
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: [email protected]
Summary
Sigachi Industries Limited was originally incorporated as Sigachi Chloro-Chemicals Private Limited on 11 January, 1989. To diversify the business activities, name of the Company was changed to Sigachi...
Read More
Reports by Sigachi Industries Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.